Tumor necrosis factor receptor and ligand superfamily family members TNFRSF14 and LIGHT: New players in human atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 12, 2001, Pages 1873-1875

  Bobik, Alex ^a   Kalinina, Natalia ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; LIGAND; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; EDITORIAL; HUMAN; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0035570663     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/atvb.21.12.1873     Document Type: Editorial

References (31)

1. Human atherosclerosis, II: Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions
2. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima: Role of cell-reediated immunity in human atherogenesis
3. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque
4. Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tumor necrosis factor-α and interleukin-1β
5. The TNF and TNF receptor superfamilies: Integrating mammalian biology
6. The transcription factor NF-κB and the regulation of vascular function
7. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
8. p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells
9. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
10. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells
11. Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle cells and endothelial cells and promotes elaboration of active interleukin 1beta
12. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
13. Activation of monocyte/macrophage functions related to acute atheroma complications by ligation of CD40: Induction of collagenase, stromelysin and tissue factor
14. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
15. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
16. Macrophages, smooth muscle cells, endothelial cells and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor and CD16 (Fc gammaRIII)
17. Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions
18. TNFRSF14 is involved in atherogenesis by inducing pro-inflammatory cytokines and matrix metalloproteinases
19. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT downregulates its own receptor
20. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family
21. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-κB and AP-1
22. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation
23. IL-8 is an angiogenic factor in human coronary atherectomy tissue
24. Interelukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque
25. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
26. LIGHT, a novel ligand for lymphotoxin β receptor and TRS/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer
27. Discrete signaling regions in the lymphotoxin-β receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization and activation of cell death and NF-κB pathways
28. Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types
29. Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor and Fas) in human lung
30. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
31. The lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells